Physicians at Baltimore VA Say They Prefer Filmless Radiology System

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 6 No 7
Volume 6
Issue 7

BOSTON--A medical center that has gone to a completely filmless radiology department got a show of support from the medical and surgical staff.

BOSTON--A medical center that has gone to a completely filmless radiologydepartment got a show of support from the medical and surgical staff.

In a survey conducted after the system had been in use for three years,more than three fourths of respondents (78%) at the Baltimore VA MedicalCenter said they strongly preferred the filmless system over conventionalx-ray film. Only 7% said they still preferred film, and 15% had no preference.

The Picture Archival and Communications System (PACS) in operation atthe Baltimore VA is a digital medical imaging network that can be usedby the entire hospital staff for storing and retrieving radiologic images.Overall, PACS results in increased efficiency, improved availability ofimages, and better use of physicians' time, lead investigator Zenon Protopapas,MD, said at the American Roentgen Ray Society annual meeting.

Dr. Protopapas, who was on the radiology staff at the VA hospital whenthe study was conducted, is now affiliated with the Hospital of St. Raphael,New Haven, Conn.

Questionnaires were mailed to 280 attending physicians, residents, andphysician assistants, most of whom worked both at the filmless BaltimoreVA and the film-based University of Maryland Hospital. The response ratewas 40%.

The feeling that the filmless system contributes to a more efficientuse of clinical time was almost universal, with 90% of respondents in agreement.Close to 80% of those surveyed said the filmless system actually savedtime--on average, 36 minutes per day per physician. The respondents reportedaccessing the system a median of three to five times a day.

More than half (57%) said that PACS use did not change the frequencywith which they consult with radiologists; 35% reported a decreased frequency,and 8% reported an increase.

Recent Videos
The approval of daratumumab validates the notion of using limited therapy to help delay progression from smoldering disease to multiple myeloma.
According to Aditya Bardia, MD, MPH, FASCO, antibody-drug conjugates are slowly replacing chemotherapy as a standard treatment for breast cancer.
A simulation procedure helped to ascertain chemotherapy tolerability before administering radioembolization therapy for NETs with liver metastases.
The addition of radioembolization to radiosensitizing chemotherapy may help concurrently treat patients with liver tumors and disease outside the liver.
In neuroendocrine tumor management, patients with insulinoma may be at risk of severe hypoglycemia following receipt of GLP-1 receptor agonists.
Decreasing the low-dose bath of proton therapy to the body may limit the impact of radiation on lymphocytes and affect tumor response.
4 experts are featured in this series.
4 experts are featured in this series.
According to Eyub Akdemir, MD, reducing EDIC may be feasible without compromising target coverage to reduce anticipated lymphopenia rates.
7 experts are featured in this series.
Related Content